glp-1 microdosing chart One Size Does Not Fit All: Understanding Semaglutide for Diabetes in Multidose Pens Microdosing GLP-1s: Risks & Considerations

Endogenous hyperinsulinemia may cause weight gain and obesity [30], and treatment with insulin causes substantial weight gain, and may even increase cardiovascular risk [31]

doi: 10.1016/J.JDIACOMP.2024.108834 101 VarnumAAPozziEDeebelNAEvansAEidNSadeghi-NejadHet al

The former involved surgically connecting the stomach to the small intestine to bypass part of the digestive tract

There have also been dosing errors caused by patients miscalculating and self-administering dangerous levels of unapproved drugs, leading to serious side effects and hospitalization

The effects of dipeptidyl peptidase-4 inhibitors on bone fracture among patients with type 2 diabetes mellitus: a network meta-analysis of randomized controlled trials